Greene John

CIK 00016107325 companiesFALLS CHURCH, VA

SEC Profile

Transactions

Companies

Filings

CIK

0001610732

Recent Transactions

50 trades

Award
CRISPR Therapeutics AG$CRSP
Stock Option (Right to Buy)
2025-06-05+13,000→ 13,000 total
Disposition to Issuer
Discover Financial Services
Common Stock
2025-05-18−79,943→ 0 total
Purchase
CRISPR Therapeutics AG$CRSP
Common Shares
2025-02-26$44.85/sh+7,000→ 7,000 total
Tax Payment
Discover Financial Services
Common Stock
2025-02-01$201.09/sh−1,840→ 79,866 total
Award
Discover Financial Services
Common Stock
2025-01-23+14,630→ 81,706 total
Tax Payment
Discover Financial Services
Common Stock
2024-12-19$169.27/sh−11,702→ 67,076 total
Award
Discover Financial Services
Common Stock
2024-12-19+12,109→ 78,778 total
Award
CRISPR Therapeutics AG$CRSP
Stock Option (Right to Buy)
2024-05-30+13,000→ 13,000 total
Award
Discover Financial Services
Common Stock
2024-02-22+9,051→ 66,478 total
Award
Discover Financial Services
Common Stock
2024-02-22+29,324→ 57,427 total
Award
Discover Financial Services
Common Stock
2024-02-01+21,801→ 40,393 total
Tax Payment
Discover Financial Services
Common Stock
2024-02-01$106.56/sh−12,290→ 28,103 total
Tax Payment
Discover Financial Services
Common Stock
2024-02-01$106.56/sh−12,290→ 28,103 total
Award
Discover Financial Services
Common Stock
2024-02-01+21,801→ 40,393 total
Sale
Discover Financial Services
Common Stock
2024-01-26$106.51/sh−35,191→ 18,592 total
Award
CRISPR Therapeutics AG$CRSP
Stock Option (Right to Buy)
2023-06-08+13,000→ 13,000 total
Award
Discover Financial Services
Common Stock
2023-02-23+9,960→ 53,539 total
Award
Discover Financial Services
Common Stock
2023-02-01+25,196→ 57,662 total
Tax Payment
Discover Financial Services
Common Stock
2023-02-01$115.83/sh−14,083→ 43,579 total
Tax Payment
Discover Financial Services
Common Stock
2022-08-01$102.22/sh−1,752→ 32,275.457 total
Award
CRISPR Therapeutics AG$CRSP
Stock Option (Right to Buy)
2022-06-09+12,000→ 12,000 total
Award
Discover Financial Services
Common Stock
2022-02-25+7,339→ 33,952 total
Sale
Discover Financial Services
Common Stock
2022-02-15$127.95/sh−4,443→ 26,613 total
Tax Payment
Discover Financial Services
Common Stock
2022-02-01$118.02/sh−2,079→ 31,056 total
Tax Payment
Discover Financial Services
Common Stock
2021-08-01$124.32/sh−1,752→ 33,135 total
Award
CRISPR Therapeutics AG$CRSP
Stock Option (Right to Buy)
2021-06-10+10,000→ 10,000 total
Award
Discover Financial Services
Common Stock
2021-02-19−9,690→ 34,887 total
Tax Payment
Discover Financial Services
Common Stock
2021-02-01$82.19/sh−1,146→ 25,197 total
Tax Payment
Discover Financial Services
Common Stock
2020-08-01$49.43/sh−1,159→ 26,343 total
Award
CRISPR Therapeutics AG$CRSP
Stock Option (Right to Buy)
2020-06-11+15,000→ 15,000 total
Purchase
Discover Financial Services
Common Stock
2020-01-27$73.84/sh+3,377→ 27,502 total
Award
Discover Financial Services
Common Stock
2020-01-22+11,198→ 24,125 total
Award
Discover Financial Services
Common Stock
2019-09-18+11,861→ 12,927 total
Award
CRISPR Therapeutics AG$CRSP
Stock Option (Right to Buy)
2019-06-11+30,000→ 30,000 total
Disposition to Issuer
Bioverativ Inc.
Non-Qualified Stock Option
2018-03-08−113,230→ 0 total
Disposition to Issuer
Bioverativ Inc.
Restricted Stock Units
2018-03-08−42,727→ 0 total
Disposition to Issuer
Bioverativ Inc.
Non-Qualified Stock Option
2018-03-08−56,615→ 0 total
Disposition to Issuer
Bioverativ Inc.
Common Stock
2018-03-08−5,951.011→ 0 total
Disposition to Issuer
Bioverativ Inc.
Restricted Stock Units
2018-03-08−14,230→ 0 total
Tax Payment
Bioverativ Inc.
Common Stock
2018-02-14$103.52/sh−2,118→ 5,496.057 total
Exercise/Conversion
Bioverativ Inc.
Common Stock
2018-02-14+7,114→ 7,614.057 total
Exercise/Conversion
Bioverativ Inc.
Restricted Stock Units
2018-02-14−7,114→ 14,230 total
Award
Bioverativ Inc.
Restricted Stock Units
2018-01-31+42,727→ 42,727 total
Award
Bioverativ Inc.
Non-Qualified Stock Option
2017-02-14+113,028→ 113,028 total
Award
Bioverativ Inc.
Non-Qualified Stock Option
2017-02-14+56,615→ 56,615 total
Award
Bioverativ Inc.
Non-Qualified Stock Option
2017-02-14+113,230→ 113,230 total
Award
Bioverativ Inc.
Non-Qualified Stock Option
2017-02-14+56,514→ 56,514 total
Award
Bioverativ Inc.
Restricted Stock Units
2017-02-14+21,344→ 21,344 total
Award
WILLIS TOWERS WATSON PLC$WTW
Ordinary Shares, nominal value $0.000304635 per share
2016-01-04+3,913→ 14,805 total
Award
WILLIS TOWERS WATSON PLC$WTW
Ordinary Shares, nominal value $0.000115 per share
2015-11-09+15,323→ 28,855 total

Greene John

Recent Transactions

Companies

Recent Filings

Address